Previous 10 | Next 10 |
2023-10-03 08:41:53 ET Gainers: Alx Oncology ( ALXO ) +116% . Vericity ( VERY ) +95% Strengthens Individual Insurance Presence in the United States with the Acquisition of Vericity. POINT Biopharma Global ( PNT ) +85% to acquire Point ...
2023-09-21 11:04:07 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’re putting together a list of overlooked AI stocks, I wouldn’t try to sneak Nvidia (NASDAQ: NVDA ) on it. Even investor neophytes know about CEO Jensen Huan...
2023-09-20 14:13:07 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Artificial intelligence is still all the rage with investors, but the hype has pushed many stocks to unsustainable heights. Now that the irrational frenzy is cooling off, some compelling opport...
BEDFORD, Mass., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, an...
2023-08-30 16:00:30 ET Summary Lantheus Holdings, Inc. stock sold off sharply after Q2 numbers, and is now trading at July '22 range. Q2 earnings showed solid growth, but LNTH's economic profitability and market technicals are concerning. LNTH divested its RELISTOR royalties, ...
2023-08-30 08:20:15 ET Summary Radiopharmacy is expected to experience exponential growth over the next decade. Radiopharmaceutical-based therapies offer more targeted and specific approaches for cancer treatment and medical imaging, with prostate cancer proving to be a particular...
2023-08-18 08:43:41 ET More on Lantheus Lantheus: Pylarify And Definity Driving Strong Growth POINT Biopharma slips after pipeline update Lantheus prostate cancer diagnostics recommended for EU approval Lantheus soars 15% on Q1 beat, beats Q2 and FY forecast ...
2023-08-14 10:46:36 ET More on POINT Biopharma POINT Biopharma: Leading The Future Of Radioligand Therapy POINT Biopharma: Stock Has Upcoming Catalysts With 2 Therapies In Phase 3 Trials POINT Biopharma: Navigating The Radioligand Therapy Landscape With Strong Financ...
2023-08-03 16:16:02 ET Lantheus Holdings, Inc. (LNTH) Q2 2023 Earnings Conference Call August 03, 2023 08:00 AM ET Company Participants Mark Kinarney - Vice President of Investor Relations Mary Anne Heino - Chief Executive Officer Paul Blanchfield - President ...
2023-08-03 09:05:43 ET Aravive ( ARAV ) -58% announces top-line results from phase 3 AXLerate-OC study of batiraxcept in patinum-resistant ovarian cancer. Vicarious Surgical ( RBOT ) -41% on pricing $45M offering . DXC Technology Company ( DXC ) -24% ...
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...
BEDFORD, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced its acqu...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...